Rare Disease Therapeutics, Inc.
Rare Disease Therapeutics, Inc. (RDT) is America’s first exclusively orphan drug company committed to developing and marketing drugs for rare disorders, primarily in the areas of oncology, hematology, and envenomation. RDT is dedicated to patients with unmet medical needs that have been overlooked by other pharmaceutical companies.